GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 24477.48 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 871.22 Crore, down -1.93 % from last quarter Total Income of Rs 888.36 Crore and up 9.58 % from last year same quarter Total Income of Rs 795.09 Crore. Company reported net profit after tax of Rs 156.51 Crore in latest quarter.
Investment Rationale
The brokerage expects this trend in recovery in the acute therapies to continue in the coming quarters. GSKP’s exposure only to domestic formulations, strong balance sheet and strong brand equity augurs well.
Promoter/FII Holdings
Promoters held 75 per cent stake in the company as of Dec 30, 2020, while FIIs held 1.5 per cent, DIIs 5.3 per cent and public and others 18.2 per cent.
